Differences in antigen-specific cd4+ responses to opportunistic infections in hiv infection

Immunity, Inflammation and Disease

Volumn 3, Issue 3, 2015, Pages 141-153

  Pollock, Katrina M ^a   Montamat Sicotte, Damien J ^a   Cooke, Graham S ^b   Kapembwa, Moses S ^c   Kon, Onn M ^d   Grass, Lisa ^a   Sampson, Robert D ^a   Taylor, Graham P ^b   Lalvani, Ajit ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c EALING HOSPITAL NHS TRUST   (United Kingdom)

^d ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Candida albicans; Cytomegalovirus; Epstein Barr virus; HIV; Mycobacterium tuberculosis

Indexed keywords

EID: 84954535034     PISSN: None     EISSN: 20504527     Source Type: Journal    
DOI: 10.1002/iid3.50     Document Type: Article

References (38)

1. WHO, TB/HIV facts 2011.
2. ECDC/WHO, Tuberculosis surveillance in Europe 2009.
3. Oni, T., R. Burke, R. Tsekela, N. Bangani, R. Seldon, H.P. Gideon, K. Wood, K. A. Wilkinson, T. H. Ottenhoff, and R. J. Wilkinson. 2011. High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening. Thorax 66:669–673.
4. Sonnenberg, P., J. R. Glynn, K. Fielding, J. Murray, P. Godfrey-Faussett, and S. Shearer. 2005. How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J. Infect. Dis. 191:150–158.
5. Lawn, S. D., A. D. Harries, B. G. Williams, R. E. Chaisson, E. Losina, K. M. De Cock, and R. Wood. 2011. Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? Int. J. Tuberc. Lung Dis. 15:571–581.
6. Bronke, C., N. M. Palmer, C. A. Jansen, G. H. Westerlaken, A. M. Polstra, P. Reiss, M. Bakker, F. Miedema, K. Tesselaar, and D. van Baarle. 2005. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease. J. Infect. Dis. 191:873–880.
7. Petrara, M. R., R. Freguja, K. Gianesin, M. Zanchetta, and A. De Rossi. 2013. Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection. Front. Microbiol. 4:311.
8. Engels, E. A., R. M. Pfeiffer, O. Landgren, and R. D. Moore. 2010. Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era. J. Acquir. Immune Defic. Syndr. 54:78–84.
9. Owotade, F. J., M. Patel, T. R. Ralephenya, and G. Vergotine. 2013. Oral Candida colonization in HIV-positive women: associated factors and changes following antiretroviral therapy. J. Med. Microbiol. 62:126–132.
10. Nkuize, M., S. De Wit, V. Muls, M. Arvanitakis, and M. Buset. 2010. Upper gastrointestinal endoscopic findings in the era of highly active antiretroviral therapy. HIV Med. 11:412–417.
11. Miranda, A., M. Morgan, L. Jamal, K. Laserson, D. Barreira, G. Silva, J. Santos, C. Wells, P. Paine, and D. Garrett. 2007. Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995–2001. PLoS ONE 2:e826.
12. Lawn, S. D, L. G. Bekker, and R. Wood. 2005. How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control. AIDS 19:1113–1124.
13. Dunham, R. M., B. Cervasi, J. M. Brenchley, H. Albrecht, A. Weintrob, B. Sumpter, J. Engram, S. Gordon, N. R. Klatt, I. Frank, et al. 2008. CD127 and, CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection. J. Immunol. 180:5582–5592.
14. Lawn, S. D., M. Badri, and R. Wood. 2005. Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS 19:2109–2116.
15. Geldmacher, C., N. Ngwenyama, A. Schuetz, C. Petrovas, K. Reither, E. J. Heeregrave, J. P. Casazza, D. R. Ambrozak, M. Louder, W. Ampofo, et al. 2010. Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. J. Exp. Med. 207:2869– 2881.
16. Hu, H., M. Nau, P. Ehrenberg, A. L. Chenine, C. Macedo, Y. Zhou, Z. J. Daye, Z. Wei, M. Vahey, N. L. Michael, et al. 2013. Distinct gene-expression profiles associated with the susceptibility of pathogen-specific CD4 T cells to HIV-1 infection. Blood 121:1136–1144.
17. Day, C. L., N. Mkhwanazi, S. Reddy, Z. Mncube, M. van der Stok, P. Klenerman, and B. D. Walker. 2008. Detection of polyfunctional Mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons. J. Infect. Dis. 197:990–999.
18. Harari, A., F. Vallelian, P. R. Meylan, and G. Pantaleo. 2005. Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J. Immunol. 174:1037–1045.
19. Harari, A., S. Petitpierre, F. Vallelian, and G. Pantaleo. 2004. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 103:966–972.
20. Boaz, M. J., A. Waters, S. Murad, P. J. Easterbrook, and A. Vyakarnam. 2002. Presence of HIV-1 Gag-specific IFN-gamma + IL-2+ and CD28 + IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection. J. Immunol. 169:6376–6385.
21. Casey, R., D. Blumenkrantz, K. Millington, D. Montamat-Sicotte, O. M. Kon, M. Wickremasinghe, S. Bremang, M. Magtoto, S. Sridhar, D. Connell, et al. 2010. Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis. PLoS ONE 5:e15619.
22. Day, C. L., D. A. Abrahams, L. Lerumo, E. Janse van Rensburg, L. Stone, T. O’Rie, B. Pienaar, M. de Kock, G. Kaplan, H. Mahomed, et al. 2011. Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J. Immunol. 187:2222–2232.
23. Lalvani, A., and K. A. Millington. 2008. T cells and tuberculosis: beyond interferon-gamma. J. Infect. Dis. 197:941– 943.
24. Lahey, T., S. Sheth, M. Matee, R. Arbeit, C. R. Horsburgh, L. Mtei, T. Mackenzie, M. Bakari, J. M. Vuola, K. Pallangyo, et al. 2010. Interferon gamma responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis. J. Infect. Dis. 202:1265–1272.
25. Kalsdorf, B. T. J. Scriba, K. Wood, C. L. Day, K. Dheda, R. Dawson, W. A. Hanekom, C. Lange, and R. J. Wilkinson. 2009. HIV-1 Infection impairs the bronchoalveolar T-Cell Response to Mycobacteria. Am. J. Respir. Crit. Care Med. 180:1262–1270.
26. Chetoui, N., M. Boisvert, S. Gendron, and F. Aoudjit, 2010. Interleukin-7 promotes the survival of human CD4+ effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway. Immunology 130:418–426.
27. Schluns, K. S., and L. Lefrancois. 2003. Cytokine control of memory T-cell development and survival. Nat. Rev. Immunol. 3:269–279.
28. Appay, V., P. R. Dunbar, M. Callan, P. Klenerman, G. M. Gillespie, L. Papagno, G. S. Ogg, A. King, F. Lechner, C. A. Spina, et al. 2002. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8:379–385.
29. Riou, C., F. Treurnicht, M. R. Abrahams, K. Mlisana, M. K. Liu, N. Goonetilleke, R. Koup, M. Roederer, S. Abdool Karim, G. de Bruyn, et al. 2012. Increased memory differentiation is associated with decreased polyfunctionality for HIV but not for cytomegalovirus-specific CD8+ T cells. J. Immunol. 189:3838–3847.
30. Libri, V. R. I. Azevedo, S. E. Jackson, D. Di Mitri, R. Lachmann, S. Fuhrmann, M. Vukmanovic-Stejic, K. Yong, L. Battistini, F. Kern, et al. 2011. Cytomegalovirus infection induces the accumulation of short-lived, multifunctional CD4+ CD45RA+ CD27+ T cells: the potential involvement of interleukin-7 in this process. Immunology 132:326– 339.
31. Sallusto, F., J. Geginat, and A. Lanzavecchia. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22:745– 763.
32. Pollock, K. M., H. S. Whitworth, D. J. Montamat-Sicotte, L. Grass, G. S. Cooke, M. S. Kapembwa, O. M. Kon, R. D. Sampson, G. P. Taylor, and A. Lalvani. 2013. T-cell immunophenotyping distinguishes active from latent tuberculosis. J. Infect. Dis. 208:952–968.
33. Freeman, G. J., E. J. Wherry, R. Ahmed, and A. H. Sharpe, 2006. Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J. Exp. Med. 203:2223–2227.
34. Porichis, F., D. S. Kwon, J. Zupkosky, D. P. Tighe, A. McMullen, M. A. Brockman, D. F. Pavlik, M. Rodriguez-Garcia, F. Pereyra, G. J. Freeman, et al. 2011. Responsiveness of HIV-specific CD4 T cells to PD-1 blockade. Blood 118:965–974.
35. Jurado, J. O. I. B. Alvarez, V. Pasquinelli, G. J. Martinez, M. F. Quiroga, E. Abbate, R. M. Musella, H. E. Chuluyan, and V. E. Garcia. 2008. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J. Immunol. 181:116–125.
36. Lazar-Molnar, E. B. Chen, K. A. Sweeney, E. J. Wang, W. Liu, J. Lin, S. A. Porcelli, S. C. Almo, S. G. Nathenson, and W. R. Jacobs Jr. 2010. Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 107:13402–13407.
37. Dosanjh, D. P., T. S. Hinks, J. A. Innes, J. J. Deeks, G. Pasvol, S. Hackforth, H. Varia, K. A. Millington, R. Gunatheesan, V. Guyot-Revol, et al. 2008. Improved diagnostic evaluation of suspected tuberculosis. Ann. Intern. Med. 148:325–336.
38. Amyes, E., C. Hatton, D. Montamat-Sicotte, N. Gudgeon, A. B. Rickinson, A. J. McMichael, and M. F. Callan. 2003. Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection. J. Exp. Med. 198:903–911.